MedTrace Logo

Topical Itraconazole in Treating Patients With Basal Cell Cancer

NCT02735356 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2019-04-11

No results posted yet for this study

Summary

This phase 0 trial studies how well itraconazole gel works in treating patients with basal cell cancer. Itraconazole gel may help to treat basal cell tumors in patients.

Conditions

  • Skin Basal Cell Carcinoma

Interventions

DRUG

Itraconazole

Applied topically

OTHER

Placebo

Applied topically

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Jean Yuh Tang

    lead OTHER

Principal Investigators

  • Anthony Oro · Stanford Cancer Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-05
Primary Completion
2017-09-19
Completion
2017-10-10
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02735356 on ClinicalTrials.gov